Home6185 • HKG
add
Cansino Biologics Inc
Previous close
$31.90
Day range
$31.00 - $32.08
Year range
$25.25 - $56.55
Market cap
12.96B HKD
Avg Volume
72.59K
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
Market news
Financials
Income Statement
Revenue
Net income
| (CNY) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 375.34M | 34.40% |
Operating expense | 477.84M | 24.44% |
Net income | 13.43M | 108.58% |
Net profit margin | 3.58 | 106.39% |
Earnings per share | — | — |
EBITDA | 77.71M | 144.44% |
Effective tax rate | -1.37% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | — | — |
Total assets | — | — |
Total liabilities | — | — |
Total equity | — | — |
Shares outstanding | 291.55M | — |
Price to book | — | — |
Return on assets | — | — |
Return on capital | 1.23% | — |
Cash Flow
Net change in cash
| (CNY) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 13.43M | 108.58% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
CanSino Biologics, often abbreviated as CanSinoBIO, is a Chinese vaccine company. Wikipedia
CEO
Founded
Jan 13, 2009
Website
Employees
1,115
